Zevra Therapeutics, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↑+59.8% +$107M
$285M
Current Assets↑+159.2% +$137M
$223M
Cash & Equivalents↑+84.7% +$29M
$62M
ST Investments
—
Receivables
$10M
Inventory↓-11.7% -$230K
$2M
Net PPE↑+37.4% +$133K
$489K
Goodwill↑+0.0% +$0
$5M
Intangibles↓-90.7% -$63M
$6M
Total Liabilities↓-6.1% -$8M
$130M
Current Liabilities↑+15.3% +$5M
$39M
Account Payables↓-81.0% -$11M
$2M
Long-Term Debt↑+4.1% +$2M
$62M
Stockholders Equity↑+289.9% +$115M
$155M
Retained Earnings↑+16.5% +$83M
$-422M
Operating Lease ROU Asset↑+84.5% +$555K
$1M
Operating Lease Liability↑+61.4% +$486K
$1M
Finance Lease ROU Asset↓-95.6% -$109K
$5K
Gross PP&E
$2M
Accumulated Depreciation
$2M
Inventory Raw Materials↓-99.9% -$8M
$7K
Inventory WIP↓-45.4% -$1M
$2M
Inventory Finished Goods↓-53.3% -$949K
$832K
Debt Due Y1
$0
Debt Due Y2
$0
Debt Due Y3
$0
Debt Due Y4
$64M
Total Debt Carrying Amount↑+3.3% +$2M
$64M
Contract Liability
$0